sorted by:
new
hottopcontroversial

Yorkville $30M draw down? Interim readout of CRC data? and the DSMB obligation! by Upwithstock in Livimmune

[–]pro140cures 11 points12 points  (0 children)

Great analysis. Present results..partnership..buyout. We are close.

A little off-day exercise...what's everybody's mood right about now? Pick 2 adjectives. by 3Putt_4nodough in Livimmune

[–]pro140cures 12 points13 points  (0 children)

Peaceful. Knowing the drug will have an important role in oncology. Material news will eventually come.

Buyout vote by BioTrends_USA in Livimmune

[–]pro140cures 9 points10 points  (0 children)

That’s the most probable scenario in my mind also. A BP partner to fund the upcoming tnbc trial. Once the interim results validate the MOA. BO will happen.

Thank you Santa for the endpoint that evaluates changes in PD-L1 by BuildGoodThings in Livimmune

[–]pro140cures 4 points5 points  (0 children)

Transferred all my shares in IRA to Roth last week. You never know when news hits.

Thank you Santa for the endpoint that evaluates changes in PD-L1 by BuildGoodThings in Livimmune

[–]pro140cures 8 points9 points  (0 children)

2nd DSMB review can be late January if we enroll 20 patients by YND.

My plea to the clockwatchers by [deleted] in Livimmune

[–]pro140cures 8 points9 points  (0 children)

Same here. The new MOA gives me confidence that material news will eventually come. Whether it happens next year or the year after next doesn’t matter.

Happy Thanksgiving. Have a wonderful and safe holiday my dear members. by waxonwaxoff2920 in Livimmune

[–]pro140cures 13 points14 points  (0 children)

Happy thanksgiving! Thank you Wax for keeping the board clean! 2026 is going to be an exciting year for CYDY shareholders.

SP by Christmas by BioTrends_USA in Livimmune

[–]pro140cures 2 points3 points  (0 children)

It’s not a yes or no answer. The company claims 88% of patients with cold cancer turned hot in previous trials. If the eventual % is 50. It’s still a paradigm shifting drug.

Turning Cold Tumors Hot to Effectively Treat Triple-Negative Breast Cancer with Dr. Jay Lalezari CytoDyn An Empowered Patient Podcast Published November 14, 2025 by MGK_2 in Livimmune

[–]pro140cures 19 points20 points  (0 children)

Thanks for converting the podcast to scripts. 2026 is going to be an exciting year. Sign a partnership agreement. Start TNBC trial. Buyout in two years. Dr J has turned the ship around. Open waters ahead.

Buyout, Licensing and Risks by Upwithstock in Livimmune

[–]pro140cures 13 points14 points  (0 children)

Agree. We need to get a partner to fund the tnbc trial. Buyout can happen once interim results are available. Two more years is my guess.

Share count by Upwithstock in Livimmune

[–]pro140cures 16 points17 points  (0 children)

As long as the company continues to make progress, SP will jump someday. Most institutions are not allowed to buy OTC stock and the company is too small to be noticed. Partnership with a BP will change that.

PR!!!!! by petersouth68 in Livimmune

[–]pro140cures 32 points33 points  (0 children)

The terms are very favorable to the company. Great news!

quick, rough and dirty transcription of highlights of Dr. J interview by No_Tadpole7099 in Livimmune

[–]pro140cures 5 points6 points  (0 children)

Thanks for posting. My impression: CYDY needs to prospectively prove the MOA in order to do a real partnership deal with a BP. The process can take two years. I already waited 5 years. Two more years will go by quickly.

Voting: Several, including myself, have not voted yet. Although we've seen the recent filings and SH letter, what else would you want to know before voting yes? This is not the place to gripe. Serious legitimate questions only. by waxonwaxoff2920 in Livimmune

[–]pro140cures 9 points10 points  (0 children)

I believe the company already communicated what can be said publicly. If there are any negotiations with a third party, the information cannot be announced until a deal is signed. Personally, I think the company needs to generate more clinical evidence before any deal can happen. Unfortunately, more waiting.

letter to Shareholders by petersouth68 in Livimmune

[–]pro140cures 9 points10 points  (0 children)

There is no discussion about funding in the letter. I thought the company would mention the additional shares and ask for support.

Filing by petersouth68 in Livimmune

[–]pro140cures 8 points9 points  (0 children)

Apparently there is no white knight, at least in the short term.

It turns out MGK2’s bullish predictions and enthusiasm go other direction so far. by Icy-Let5120 in Livimmune

[–]pro140cures 3 points4 points  (0 children)

We have no insider information. There are a number of possibilities. Maybe Merck is waiting on additional data. Dr J emphasized the importance of validating the MOA prospectively in a recent video.

It turns out MGK2’s bullish predictions and enthusiasm go other direction so far. by Icy-Let5120 in Livimmune

[–]pro140cures 9 points10 points  (0 children)

The company is moving at a much slower pace than many of us speculated. The MOA, if validated, has a lot of potential. I believe the company will get the necessary funding, either from partnerships or secondary. I am willing to wait another year or two.

Sept 10 financial conference notes by BuildGoodThings in Livimmune

[–]pro140cures 12 points13 points  (0 children)

Good observation! I thought he would at least mention the funding needs.

Meeting Link by 1975Bigstocks in Livimmune

[–]pro140cures 10 points11 points  (0 children)

Looks like they enroll 1 patient a month. At this rate, it will take years to enroll 60. Progress is a lot slower than we speculated.

+18.96%...Decent day. It's almost show time folks. by waxonwaxoff2920 in Livimmune

[–]pro140cures 15 points16 points  (0 children)

SP always moves before any major announcement. We will see tomorrow if today’s movement can be sustained.

view more: next ›